Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Future Fuel
FF
$229M
| $29.2M | 0.03% |
2,442,800
-37,000
| -1% | -$437K |
2013 Q2
28 quarters
|
|
|
NGD
627
DELISTED
New Gold Inc
NGD
| $29M | 0.03% |
21,478,108
+1,046,754
| +5% | +$1.05M |
2017 Q3
11 quarters
|
|
628
Skywest
SKYW
$3.75B
| $29M | 0.03% |
888,436
-489,157
| -36% | -$14.5M |
2014 Q4
22 quarters
|
|
629
Ulta Beauty
ULTA
$24.4B
| $28.8M | 0.02% |
141,800
+128,000
| +928% | +$27.5M |
2019 Q4
2 quarters
|
|
630
Yelp
YELP
$1.01B
| $28.8M | 0.02% |
1,246,945
+1,112,845
| +830% | +$24.3M |
2017 Q3
11 quarters
|
|
|
NXRT
631
NexPoint Residential Trust
NXRT
$494M
| $28.8M | 0.02% |
815,710
-381,500
| -32% | -$11.8M |
2015 Q4
18 quarters
|
|
|
KBAL
632
DELISTED
Kimball International
KBAL
| $28.8M | 0.02% |
2,490,095
-137,081
| -5% | -$1.57M |
2013 Q2
28 quarters
|
|
633
Old Dominion Freight Line
ODFL
$37.7B
| $28.7M | 0.02% |
+338,682
| New | +$25.7M |
2020 Q2
0 quarters
|
|
634
Ultrapar
UGP
$8.42B
| $28.6M | 0.02% |
8,441,980
-1,652,600
| -16% | -$4.87M |
2013 Q2
28 quarters
|
|
635
Infosys
INFY
$43.5B
| $28.5M | 0.02% |
2,955,200
+44,800
| +2% | +$400K |
2020 Q1
1 quarter
|
|
636
Qualcomm
QCOM
$187B
| $28.5M | 0.02% |
312,820
-1,978,372
| -86% | -$159M |
2019 Q3
3 quarters
|
|
637
Linde
LIN
$223B
| $28.5M | 0.02% |
134,500
+16,400
| +14% | +$3.17M |
2018 Q4
6 quarters
|
|
638
Collegium Pharmaceutical
COLL
$719M
| $28.5M | 0.02% |
1,627,318
+40,700
| +3% | +$797K |
2019 Q2
4 quarters
|
|
|
AVTA
639
DELISTED
Avantax, Inc. Common Stock
AVTA
| $28.4M | 0.02% |
2,486,500
-121,800
| -5% | -$1.53M |
2013 Q2
28 quarters
|
|
640
Adient
ADNT
$1.34B
| $28.3M | 0.02% |
1,724,545
+387,800
| +29% | +$5.9M |
2018 Q3
7 quarters
|
|
641
Otter Tail
OTTR
$3.67B
| $28.3M | 0.02% |
729,010
-122,390
| -14% | -$5.15M |
2014 Q1
25 quarters
|
|
642
Bank of Montreal
BMO
$113B
| $28.3M | 0.02% |
531,927
+497,732
| +1,456% | +$25.4M |
2013 Q2
28 quarters
|
|
643
Lennar Class A
LEN
$18.2B
| $28.2M | 0.02% |
+473,355
| New | +$24.2M |
2020 Q2
0 quarters
|
|
644
Salesforce
CRM
$189B
| $28.2M | 0.02% |
150,681
-144,490
| -49% | -$24.3M |
2019 Q2
4 quarters
|
|
|
SOHU
645
Sohu.com
SOHU
$332M
| $28.1M | 0.02% |
3,056,455
-87,600
| -3% | -$683K |
2014 Q2
24 quarters
|
|
|
ALE
646
DELISTED
Allete
ALE
| $27.9M | 0.02% |
511,606
-349,355
| -41% | -$19.8M |
2016 Q1
17 quarters
|
|
647
SS&C Technologies
SSNC
$19B
| $27.8M | 0.02% |
492,300
-236,300
| -32% | -$12.9M |
2019 Q4
2 quarters
|
|
648
Sibanye-Stillwater
SBSW
$7.08B
| $27.8M | 0.02% |
3,210,130
-3,049,504
| -49% | -$23.2M |
2018 Q3
7 quarters
|
|
649
Monolithic Power Systems
MPWR
$68.1B
| $27.7M | 0.02% |
116,786
+90,300
| +341% | +$18.3M |
2020 Q1
1 quarter
|
|
650
MSCI
MSCI
$41.1B
| $27.6M | 0.02% |
82,721
-384,569
| -82% | -$124M |
2016 Q2
16 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.